14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of SNDX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Syndax Pharmaceuticals Inc stock downgraded to Sell Candidate
(Updated on Apr 25, 2024)

Sell candidate since Apr 25, 2024 PDF

The Syndax Pharmaceuticals Inc stock price fell by -1.06% on the last day (Thursday, 25th Apr 2024) from $20.79 to $20.57. During the last trading day the stock fluctuated 3.33% from a day low at $20.13 to a day high of $20.80. The price has fallen in 7 of the last 10 days and is down by -7.84% for this period. Volume has increased on the last day by 209 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 559 thousand shares were bought and sold for approximately $11.49 million.

The stock is at the lower part of a wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $20.48 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect Syndax Pharmaceuticals Inc stock with a 90% probability to be traded between $20.39 and $24.40 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

SNDX Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 0.390%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Syndax Pharmaceuticals Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $20.76 and $22.44. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Syndax Pharmaceuticals Inc stock

Syndax Pharmaceuticals Inc finds support from accumulated volume at $20.49 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.670 between high and low, or 3.33%. For the last week, the stock has had daily average volatility of 3.08%.

Syndax Pharmaceuticals Inc is oversold on RSI14 (23). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (SNDX) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Syndax Pharmaceuticals Inc to open at $20.50, and during the day (based on 14 day Average True Range), to move between $19.73 and $21.41, which gives a possible trading interval of +/-$0.84 (+/-4.10%) up or down from last closing price. If Syndax Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 8.19% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $20.49 (0.39%) than the resistance at $20.74 (0.83%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Syndax Pharmaceuticals Inc stock A Buy?

Syndax Pharmaceuticals Inc holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -1.209 Sell Candidate Downgraded

Predicted Opening Price for Syndax Pharmaceuticals Inc of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$20.50 ( 0.340%) $20.57

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for SNDX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 21.17 2.92 %
R2 20.91 1.67 %
R1 20.76 0.90 %
Current price: 20.57
Support S1 20.24 -1.58 %
S2 20.09 -2.35 %
S3 19.83 -3.60 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 24.57 19.45 %
R2 23.52 14.34 %
R1 20.74 0.83 %
Current price 20.57
Support S1 20.49 -0.389%
S2 20.32 -1.22%
S3 20.22 -1.70%

FAQ

What is the symbol for Syndax Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for Syndax Pharmaceuticals Inc is SNDX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Syndax Pharmaceuticals Inc Stock?
Syndax Pharmaceuticals Inc holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Syndax Pharmaceuticals Inc Stock?
Syndax Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Syndax Pharmaceuticals Inc Stock.

What's the current price of Syndax Pharmaceuticals Inc Stock?
As of the end of day on the Apr 25, 2024, the price of an Syndax Pharmaceuticals Inc (SNDX) share was $20.57.

What is the 52-week high and low for Syndax Pharmaceuticals Inc Stock?
The 52-week high for Syndax Pharmaceuticals Inc Stock is $25.34 and the 52-week low is $11.23.

What is the market capitalization of Syndax Pharmaceuticals Inc Stock?
As of the Apr 25, 2024, the market capitalization of Syndax Pharmaceuticals Inc is 1.748B.

When is the next earnings date for Syndax Pharmaceuticals Inc?
The upcoming earnings date for Syndax Pharmaceuticals Inc is May 13, 2024.
Click to get the best stock tips daily for free!

About Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML); and SNDX-6352 or axatilimab, a monoclonal antibody that b... SNDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT